Congenital pulmonary venous return anomaly

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:3090
Who is this for?
Show terms as
1Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Congenital pulmonary venous return anomaly, also known as anomalous pulmonary venous connection or anomalous pulmonary venous drainage, is a group of congenital heart defects in which the pulmonary veins — the blood vessels that carry oxygen-rich blood from the lungs back to the heart — do not connect normally to the left atrium. Instead, they drain abnormally into the right atrium or into systemic veins such as the superior vena cava, inferior vena cava, or coronary sinus. This results in a left-to-right shunt, meaning oxygenated blood is recirculated through the lungs rather than being delivered to the body. The condition can be total (TAPVR/TAPVC), where all four pulmonary veins are anomalously connected, or partial (PAPVR/PAPVC), where only one or more veins are affected. In total anomalous pulmonary venous return, symptoms typically present in the neonatal period and can be severe, including cyanosis (bluish discoloration of the skin), respiratory distress, poor feeding, failure to thrive, and signs of right heart failure. An atrial septal defect or patent foramen ovale is necessary for survival, as it allows some oxygenated blood to reach the left side of the heart and systemic circulation. If the anomalous venous drainage is obstructed, the condition constitutes a surgical emergency with rapid clinical deterioration. Partial forms may be milder and sometimes remain undiagnosed until later in childhood or adulthood, presenting with symptoms of volume overload of the right heart such as fatigue, exercise intolerance, and recurrent respiratory infections. Diagnosis is made through echocardiography, cardiac catheterization, CT angiography, or cardiac MRI. The primary treatment is surgical correction, which involves redirecting the pulmonary venous flow to the left atrium. For total anomalous pulmonary venous return, surgery is typically performed in the neonatal period and is considered urgent, especially in obstructed forms. Outcomes have improved significantly with advances in pediatric cardiac surgery, though postoperative complications such as pulmonary vein stenosis can occur and may require further intervention. Long-term follow-up with a cardiologist is essential.

Also known as:

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Congenital pulmonary venous return anomaly.

View clinical trials →

No actively recruiting trials found for Congenital pulmonary venous return anomaly at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Congenital pulmonary venous return anomaly community →

Specialists

1 foundView all specialists →
NM
Nathaniel Sznycer-Taub, MD
ANN ARBOR, MI
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Congenital pulmonary venous return anomaly.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Congenital pulmonary venous return anomalyForum →

No community posts yet. Be the first to share your experience with Congenital pulmonary venous return anomaly.

Start the conversation →

Latest news about Congenital pulmonary venous return anomaly

No recent news articles for Congenital pulmonary venous return anomaly.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Congenital pulmonary venous return anomaly

What is Congenital pulmonary venous return anomaly?

Congenital pulmonary venous return anomaly, also known as anomalous pulmonary venous connection or anomalous pulmonary venous drainage, is a group of congenital heart defects in which the pulmonary veins — the blood vessels that carry oxygen-rich blood from the lungs back to the heart — do not connect normally to the left atrium. Instead, they drain abnormally into the right atrium or into systemic veins such as the superior vena cava, inferior vena cava, or coronary sinus. This results in a left-to-right shunt, meaning oxygenated blood is recirculated through the lungs rather than being deliv

At what age does Congenital pulmonary venous return anomaly typically begin?

Typical onset of Congenital pulmonary venous return anomaly is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Congenital pulmonary venous return anomaly?

1 specialists and care centers treating Congenital pulmonary venous return anomaly are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.